Engineering the world's fastest swimsuit

A highly specialised computer modelling technique developed at The University of Nottingham has been instrumental in the design of a revolutionary new swimsuit which is now being hailed as the fastest in the world.

Dr Herve Morvan, a lecturer in fluid mechanics in the School of Mechanical, Materials and Manufacturing Engineering, is working as an advisor to the AQUALAB, Speedo’s competition research and development department, responsible for the development of Speedo’s new LZR Racer swimsuit.

Within a week of its launch athletes wearing the new swimsuit had broken three world records.

Speedo harnessed the expertise of NASA and a number of international research institutes and industrial partners such as ANSYS, one of the world’s leading engineering simulation software providers, to create the new suit.

The team at Nottingham specialises in Computational Fluid Dynamics (CFD), the computer modelling of fluid flow. The technique is rapidly developing in its technology and applications and can cut design times, increase productivity and give significant insight to fluid flows.

CFD is commonly used for analysis, for example, in the Rolls Royce University Technology Centre which specialises in research for the aeronautics industry, and for many other applications relating to the energy, biomedical and sports sectors. As well as engineers, experts in the School of Mathematical Sciences and the School of Physics and Astronomy develop and use numerical modelling techniques of fluid flow to provide insight in fluid problems ranging from the atomic scale to that of the universe.

Speedo AQUALAB scanned over 400 athletes and obtained the scan for a series of top athletes. Using CFD analysis Dr Morvan and his team were able to pin-point areas of high friction on the athlete’s body. With this information designers were able to position low friction fabric, exclusively developed by Speedo, in the right locations.

Dr Morvan, a lecturer in fluid mechanics, said: “CFD enabled us to use the compressive property of the suit to shape the body as ideally as possible, taking into account the physiological and bio-mechanical requirements of the athlete.”

The new suit has 5 per cent less drag than Speedo’s 2007 suit, the FS Pro, which saw swimmers break 21 world records.

Analysis by Dr Morvan and his team at The University of Nottingham was carried out in collaboration with flume work at the University of Otago, in New Zealand and fabric tests by NASA.

Dr Morvan who is now working with Speedo towards the 2012 Olympics in London said: “We are now building up toward active drag which accounts for the athlete motion and its interaction with the free surface. This should further validate the suit design as we move to the 2012 Olympics.”

Source: University of Nottingham

Related stories:

Glaucoma surgery studied in medicare patients, new hope for people
Ophthalmologists (Eye M.D.s) continue to develop treatments to help the more than three million Americans with glaucoma. The July issue of Ophthalmology includes a large, national study of outcomes of incisional surgeries, used to reduce pressure inside the eye, in Medicare patients. Also covered is research that may brighten the outlook for patients with end-stage glaucoma.
New electrostatic-based DNA microarray technique could revolutionize medical diagnostics
The dream of personalized medicine — in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile — may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics.
Newly identified role for 'power plants' in human cells could lead to targeted therapies
Scientists have determined that human cells are able to shift important gene products into their own mitochondria, considered the power plants of cells. The finding could eventually lead to therapies for dozens of diseases.
Gene silencer and quantum dots reduce protein production to a whisper
More than 15 years ago scientists discovered a way to stop a particular gene in its tracks. The Nobel Prize-winning finding holds tantalizing promise for medical science, but so far it has been difficult to apply the technique, known as RNA interference, in living cells.


Stroke study reveals key target for improving treatment and suggests that Gleevec may help
Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.
Air travelers, astronomers stand to benefit from research on atmospheric turbulence
Anyone who frequently travels by airplane has likely experienced clear-air turbulence. It's the kind of jarring turbulence that can quickly turn a smooth flight into a bumpy ride, often causing aircraft to drop anywhere from a few feet to thousands of feet within seconds.
First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia
NYC's only medical center offering promising therapy as part of CUPID clinical trial
Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.
Caesarean sections associated with risk of asthma
Babies born by Caesarean section have a 50 % increased risk of developing asthma compared to babies born naturally. Emergency Caesarean sections increase the risk even further. This is shown in a new study based on data from 1.7 million births registered at the Medical Birth Registry at the Norwegian Institute of Public Health.

News discussion:

Technology news